Please login to the form below

Not currently logged in
Email:
Password:

Clinical

Real-world evidence

Real-world evidence Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

Sobi looks to real-world trial to push Elocta take-up

Sobi looks to real-world trial to push Elocta take-up Aims to show haemophilia A treatment’s benefit to reimbursement authorities

Allergan plans to file oral uterine fibroid drug in US by year-end

Allergan plans to file oral uterine fibroid drug in US by year-end Analysts predict treatment will reach blockbuster sales as phase III trials meet objectives

AZ tweaks immuno-oncology trials as it chases lung cancer leaders

AZ tweaks immuno-oncology trials as it chases lung cancer leaders Toughens targets for durvalumab in NSCLC monotherapy and combination study

Biogen proffers new data to support high-priced Spinraza

Biogen proffers new data to support high-priced Spinraza Trial demonstrates statistically-significant risk reduction in paediatric SMA for potential blockbuster drug

More clinical news articles

Real-world evidence

Real-world evidence Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

Opening up innovation

Opening up innovation Paul-Peter Tak on GlaxoSmithKline’s R&D strategy and the pivotal role of immunology

Opening up innovation

Opening up innovation Paul-Peter Tak on GlaxoSmithKline’s R&D strategy and the pivotal role of immunology

Allergies and asthma

Allergies and asthma Reframing the conversation from disease burden to prevention and health promotion

Can biosimilars live up to the hype?

Can biosimilars live up to the hype? Carol Lynch, chair of the European Generic Medicines Association, wants new biosimilars therapies to become routine

More clinical features

Featured jobs

Subscribe to our email news alerts

Latest intelligence

Medius Deal Watch
Deal Watch December 2016
Allergan, AZ, BMS, Pfizer, Roche and more feature in this month's pharma deals round-up...
The Young Dementia Network - much more than a logo
Welcome to the second and final part of my two-part blog....
Patient-centred care innovation in dementia: a conversation with Neil Maiden
Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Infographics